Currently out of the existing stock ratings of Leland Gershell, 232 are a BUY (95.08%), 5 are a SELL (2.05%), 7 are a HOLD (2.87%).

Leland Gershell

Work Performance Price Targets & Ratings Chart

Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 48.62% that have a potential upside of 46.14% achieved within 190 days.

Leland Gershell’s has documented 511 price targets and ratings displayed on 53 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 26-Feb-2026.

Wall Street Analyst Leland Gershell

Analyst best performing recommendations are on AVTX (AVALO THERAPEUTICS).
The best stock recommendation documented was for AVTX (AVALO THERAPEUTICS) at 8/8/2022. The price target of $1200 was fulfilled within 1 day with a profit of $259.2 (27.55%) receiving and performance score of 275.51.

Average potential price target upside

of $162.2 (39.92%) on AMRN (AMARIN PLC).
of $90.03 (15.57%) on ARGX (ARGENX NV ADR).
of $62.32 (52.13%) on ASND (ASCENDIS PHARMA AS).

ACST Acasti Pharma ADMA ADMA Biologics AGRX Agile Thrpe ALNY Alnylam Pharmaceuticals AMRN Amarin PLC ASND Ascendis Pharma AS BMRN Biomarin Pharmaceutical BXRX Baudax Bio CASI CASI Pharmaceuticals CERC Cerecor CPRX Catalyst Pharmaceuticals EVFM Evofem Biosciences MGEN Viridian Therapeutics MIST Milestone Pharmaceuticals REPH Recro Pharma TARA Protara Therapeutics URGN UroGen Pharma Ltd VERU Veru BBI Brickell Biotech PLXP PLx Pharma CRXT Clarus Therapeutics Holdings HZNP Horizon Pharma PLC LUMO Lumos Pharma AVTX Avalo Therapeutics CLNN Clene TRVI Trevi Therapeutics XLRN Acceleron Pharma CRBP Corbus Pharmaceuticals EPZM Epizyme OTLK OUTLOOK THERAPEUTICS INC SLNO Soleno Therapeutics XFOR X4 Pharmaceuticals NCNA NuCana PLC TEVA Teva Pharma Industries Ltd ADR VRDN Viridian Therapeutics CRNX Crinetics Pharmaceuticals PDSB PDS Biotechnology Corp ARGX argenx NV ADR CAPR Capricor Therapeutics CMMB Chemomab Therapeutics Ltd DRC EPIX ESSA Pharma IMVT Immunovant LGND Ligand Pharmaceuticals SABS SAB Biotherapeutics CALC CalciMedica, Common Stock DNTH Dianthus Therapeutics ENGN enGene Holdings Common Stock ACRX AcelRx Pharmaceuticals AZRX AzurRx BioPharma BBIO BridgeBio Pharma FWBI First Wave BioPharma RYTM Rhythm Pharmaceuticals XERS Xeris Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Oren Livnat (HC WAINWRIGHT)